Rallybio Corporation

RLYB | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.73

-$0.20 (-1.18%)

Sep 22, 2026, 12:46 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	858K	636K	n/a	n/a	n/a	n/a
Cost of Revenue	92K	n/a	150K	n/a	109K	62.03K
Gross Profit	766K	636K	-150K	n/a	-109K	-62.03K
Operating Income	-28.06M	-60.5M	-78.93M	-67.88M	-45.65M	-25.3M
Interest Income	2.19M	4.22M	6.15M	1.96M	54K	171K
Pretax Income	-8.98M	-57.78M	-74.56M	-66.65M	-47.01M	-26.46M
Net Income	-8.98M	-57.78M	-74.56M	-66.65M	-47.01M	-26.45M
Selling & General & Admin	14.33M	19.63M	25.39M	27.2M	18.74M	7.67M
Research & Development	19.6M	41.51M	53.54M	40.69M	26.91M	17.63M
Other Expenses	-5.09M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	28.83M	61.13M	78.93M	67.88M	45.65M	25.3M
Interest Expense	n/a	n/a	n/a	n/a	10K	49K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	28.92M	61.13M	78.93M	67.88M	45.65M	25.3M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	-15K
Shares Outstanding (Basic)	5.63M	5.44M	5.06M	3.98M	4.02M	2.78M
Shares Outstanding (Diluted)	5.63M	5.44M	5.06M	3.98M	4.02M	2.78M
EPS (Basic)	-1.59	-10.64	-14.72	-16.72	-11.68	-9.52
EPS (Diluted)	-1.59	-10.64	-14.72	-16.72	-11.68	-9.52
EBITDA	-27.97M	-60.37M	-78.78M	-67.72M	-45.39M	-25.24M
EBIT	-28.06M	-60.5M	-78.93M	-67.88M	-45.5M	-25.3M
Depreciation & Amortization	92K	131K	150K	167K	109K	62K